Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-23

FDA Approved: MALARONE — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

The FDA approved a supplemental application for Malarone (atovaquone and proguanil hydrochloride) from GlaxoSmithKline LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)

Snippet

SUPPL AP for MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)